普蕊斯（301257）：行稳致远，SMO 行业领军者开启成长新周期

Investment Rating - The report gives a "Buy" rating for the company with a target price of 93 yuan [1][12]. Core Insights - The company is positioned as a leader in the SMO (Site Management Organization) industry, benefiting from the growth in clinical trial demand, industry consolidation, and the empowerment of AI technology, indicating a new growth cycle ahead [6][7]. - The SMO industry is experiencing rapid development, with a projected annual growth rate of 15-20% for clinical trials in China over the next 3-5 years, driven by increased investment in innovative drug research [8][43]. - The company has established a strong competitive advantage through its extensive project experience, comprehensive quality control systems, and a nationwide execution network [10][52]. Financial Summary - Total revenue is projected to reach 804 million yuan in 2024, with a year-on-year growth of 5.7%, and is expected to grow to 1.305 billion yuan by 2027 [2]. - The net profit attributable to shareholders is forecasted to be 106 million yuan in 2024, with a decline of 21%, but is expected to recover to 198 million yuan by 2027, reflecting a growth of 24.4% [2]. - Earnings per share (EPS) are expected to increase from 1.35 yuan in 2024 to 2.51 yuan in 2027 [2]. Industry Overview - The SMO industry is crucial for clinical research, managing all non-medical judgment tasks in clinical trials, which enhances the efficiency of drug development [25][29]. - The number of clinical trials in China is expected to grow significantly, with 4,900 trials projected for 2024, marking a 13.9% increase from the previous year [33][39]. - The market share of leading SMO companies is anticipated to increase, with the top five players currently holding about 25-30% of the market, similar to trends observed in Japan [9][46]. Competitive Advantages - The company has a robust project experience, having managed over 4,200 projects, and maintains a strong presence in various disease areas, particularly oncology [10][57]. - The quality control system is well-established, ensuring high-quality project delivery and fostering strong client trust [63]. - The integration of AI technology is expected to enhance operational efficiency, with the company's AI-driven solutions improving information processing efficiency by 90% [11][62].